government

The Top Medical Cannabis Studies of 2017 | Leafly

84% of patients who received access to medical cannabis reduced their opioid prescriptions, compared to 45% in the comparison group.

 

In part one of this series, we took a look at some of the most impactful studies in medical cannabis, specifically those relating to CBD. This next installment highlights several cannabis wins beyond CBD, as it shows promise in healthy aging, neurodegenerative disease, and more.

Read the article on leafly.com >